<DOC>
	<DOCNO>NCT01530126</DOCNO>
	<brief_summary>The aim study evaluate safety effectiveness Platelet Derived Growth Factor ( PDGF ) mix b tricalcium phosphate ( BTCP ) treatment advance periodontal osseous defect 6 month heal .</brief_summary>
	<brief_title>Platelet Derived Growth Factor Stimulates Bone Fill Rate Attachment Level Gain</brief_title>
	<detailed_description>This triple blind , prospective parallel arm trial conduct subject require surgical treatment periodontal osseous defect .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Platelet-derived growth factor BB</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>probe depth 7mm great baseline follow debridement , 4mm great vertical bone defect depth least one intact bony wall sufficient keratinize tissue allow complete tissue coverage defect radiographic base defect least 3mm coronal apex tooth evidence localize aggressive periodontitis smoke less 1 pack cigarette per day failure maintain adequate oral hygiene pregnant woman woman intend become pregnant history oral cancer within last 6 month HIV history within last year periodontal surgery study tooth study tooth mobility great 2 study tooth exhibit class 3 furcation defect sign untreated acute infection surgical site , apical pathology , root fracture , severe root irregularity , cemental pearl , cementoenamel junction ( CEJ ) projection easily remove , untreated carious lesion CEJ root surface , subgingival restoration restoration open margin CEJ history within 6 month weekly frequent use smokeless chew tobacco , pipe cigar smoking , 20 cigarette day allergy yeast derive product investigational therapy within 30 day surgery</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>periodontitis</keyword>
</DOC>